Cosmos Health Inc（COSM）資訊與事件COSMCosmos Health Inc

Cosmos Health Projects Oliv18 to Generate Over $6M in Annual Revenue

Cosmos Health announced it is projecting Oliv18 to generate over $6M in incremental annual U.S. revenue within the next 12 to 18 months, representing approximately $4.3M in gross profit at an expected gross margin of approximately 72%.

Cosmos Health Signs Exclusive Distribution Agreement with Innova Healthcare

Cosmos Health announced an exclusive distribution agreement with Innova Healthcare covering the Company's proprietary Sky Premium Life range of food supplements across the Kingdom of Saudi Arabia. The agreement includes an initial purchase order of 126,000 units. Under the agreement, Innova is appointed sole and exclusive partner responsible for the registration, distribution, promotion, trade marketing, logistics and sale of Sky Premium Life products through pharmacies, retail shops and online platforms across the Kingdom. Innova will carry out product registration with the Saudi authorities prior to launch, in accordance with local regulatory requirements. The agreement runs for an initial term of five years, with potential to renew for a further five-year period. It also grants Innova a first right of refusal to distribute new Cosmos Health products developed, manufactured or acquired during the term.

Cosmos Health Expands Partnership with Pharma Cell

Cosmos Health announced an expansion of its partnership with Pharma Cell for the distribution of its Sky Premium Life brand in Albania. Building on the partnership the companies launched in April 2025, the company anticipates that orders under the expanded relationship will exceed 54,000 units on an annualized basis, with average monthly orders already exceeding 4,500 units.